Results 231 to 240 of about 655,167 (267)

Therapeutic options for carbapenem-resistant Enterobacteriaceae infections

Virulence, 2017
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and represents an important threat to global health. The optimal therapeutic management of carbapenem-resistant Enterobacteriaceae (CRE) infections has not been ...
Enrico Maria Trecarichi, Mario Tumbarello   +1 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Characteristics of community-acquired carbapenem-resistant Enterobacterales

Journal of Antimicrobial Chemotherapy, 2022
AbstractBackgroundCommunity-acquired carbapenem-resistant Enterobacterales (CA-CRE) are an important threat.MethodsIn CRACKLE-2, we defined patients with CA-CRE as admitted from home, without pre-existing conditions, and a positive culture within 48 h of admission.
Rima Shrestha, Courtney L Luterbach, Weixiao Dai, Lauren Komarow, Michelle Earley, Gregory Weston, Erica Herc, Jesse T Jacob, Robert Salata, Darren Wong, Deverick Anderson, Kirsten B Rydell, Cesar A Arias, Liang Chen, David van Duin, Gregory Weston, Belinda Ostrowsky, Judith J Lok, Robert A Bonomo, T Nicholas Domitrovic, Kristine M Hujer, Andrea M Hujer, Susan D Rudin, Steven H Marshall, Robert A Salata, Federico Perez, Eric Cober, Sandra S Richter, Rebekka Arias, Carol Hill, Vance G Fowler, Deverick J Anderson, Jesse T Jacob, Minggui Wang, Liang Chen, Samit Desai, Barry N Kreiswirth, Claudia Manca, Jose R Mediavilla, Gopi Patel, W Charles Huskins, Robin Patel, Sara Revolinski, Glenn Wortmann, Robert C Kalayjian, Angela Kim, Julia Garcia-Diaz, Bettina C Fries, Brandon Eilertson, Jason C Gallagher, Michelle Earley, Scott Evans, Lauren Komarow, Omai B Garner, Henry F Chambers, John J Farrell, Lilian M Abbo, Keith S Kaye, Courtney Luterbach, David van Duin, Jennifer H Han, Yohei Doi, David L Paterson, Darren Wong, Cesar A Arias, Blake Hanson, An Dinh, Diana Panesso, William Shropshire, Truc T Tran, Ritu Banerjee, Sorabh Dhar, Michael J Satlin, Matthew Grant   +73 more
openaire   +2 more sources

The Rise of Carbapenem-Resistant Acinetobacter baumannii

Current Pharmaceutical Design, 2012
Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A., Hamouda, Ahmed, Amyes, Sebastian G. B.   +2 more
openaire   +3 more sources

Options for treating carbapenem-resistant Enterobacteriaceae

Current Opinion in Infectious Diseases, 2014
To address the therapeutic management of carbapenem-resistant Enterobacteriaceae on the basis of literature of the last 12 months.Retrospective and prospective (nonrandomized noncontrolled) studies provide data regarding the management of infections due to carbapenem-resistant Enterobacteriaceae.
Petros I, Rafailidis, Matthew E, Falagas
openaire   +2 more sources

Carbapenem-resistant Enterobacteriaceae

The Meducator, 2019
.
openaire   +1 more source

[Carbapenem resistance in enterobacteria].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne, 2009
Carbapenems are the drugs of choice in the treatment of serious infections caused by multiresistant Gram-negative bacteria. Clinically and epidemiologically, resistance to these beta-lactams poses the highest risk. In enterobacteria, two common mechanisms can cause the resistance to carbapenems: (1) hydrolysis of carbapenems by beta-lactamases and (2 ...
J, Hrabák, E, Chudácková
openaire   +1 more source

Carbapenem-resistant Enterobacterales in the USA

The Lancet Infectious Diseases, 2020
Sumanth, Gandra, Carey-Ann D, Burnham
openaire   +2 more sources